The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.

Although there is one GLP-1 medication, Rybelsus, currently given as a daily pill, it has so far only been prescribed as a ...

Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the ...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

Novo Nordisk said on Tuesday its experimental obesity drug, amycretin, showed statistically significant weight loss of up to 14.5% at 36 weeks in patients with type 2 diabetes in a mid-stage study.

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

The former First Lady, 61, showed off her slimmer look in a recent social media post, with speculation swirling around her ...

Four in five people put the weight back on after coming of weight loss jabs, new research has suggested today-and they're not ...

In the pictures shot by celebrated photographer Annie Leibovitz, Obama is seen in a simple grey tee, classic blue jeans and ...

Young adults are increasingly facing type 2 diabetes risk due to stress and unhealthy habits, even if they appear thin.

Loosely regulated online platforms are promoting powerful obesity shots as a universal weight-loss solution. Photographer: ...

Dual glucagon (GCG) and GLP-1 agonist mazdutide is already approved for both type 2 diabetes and obesity in China at doses ...